299 related articles for article (PubMed ID: 32078435)
1. Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier Homeostasis.
Yang JM; Park CS; Kim SH; Noh TW; Kim JH; Park S; Lee J; Park JR; Yoo D; Jung HH; Takase H; Shima DT; Schwaninger M; Lee S; Kim IK; Lee J; Ji YS; Jon S; Oh WY; Kim P; Uemura A; Ju YS; Kim I
Circ Res; 2020 Mar; 126(6):767-783. PubMed ID: 32078435
[TBL] [Abstract][Full Text] [Related]
2. Upregulated miR-194-5p suppresses retinal microvascular endothelial cell dysfunction and mitigates the symptoms of hypertensive retinopathy in mice by targeting SOX17 and VEGF signaling.
Wan Q; Liu H; Xu Y; Zhang Q; Tao L
Cell Cycle; 2023 Feb; 22(3):331-346. PubMed ID: 36200131
[TBL] [Abstract][Full Text] [Related]
3. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
[TBL] [Abstract][Full Text] [Related]
4. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension.
Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441
[TBL] [Abstract][Full Text] [Related]
5. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
6. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
[TBL] [Abstract][Full Text] [Related]
7. Dll4-Notch1 signaling but not VEGF-A is essential for hyperoxia induced vessel regression in retina.
Zhu G; Lin Y; Liu H; Jiang D; Singh S; Li X; Yu Z; Fan L; Wang S; Rhen J; Li W; Xu Y; Ge J; Pang J
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):400-406. PubMed ID: 30448061
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
[TBL] [Abstract][Full Text] [Related]
9. Kruppel-like factor 4 regulates developmental angiogenesis through disruption of the RBP-J-NICD-MAML complex in intron 3 of Dll4.
Boriushkin E; Zhang H; Becker M; Peachey J; Shatat MA; Adams RH; Hamik A
Angiogenesis; 2019 May; 22(2):295-309. PubMed ID: 30607695
[TBL] [Abstract][Full Text] [Related]
10. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
Williams CK; Li JL; Murga M; Harris AL; Tosato G
Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
[TBL] [Abstract][Full Text] [Related]
12. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
[TBL] [Abstract][Full Text] [Related]
13. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
14. Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina.
Zhou Y; Williams J; Smallwood PM; Nathans J
PLoS One; 2015; 10(12):e0143650. PubMed ID: 26630461
[TBL] [Abstract][Full Text] [Related]
15. Dll4 Blockade Promotes Angiogenesis in Nonhealing Wounds of Sox7-Deficient Mice.
Yang JM; Ryu J; Kim I; Chang H; Kim IK
Adv Wound Care (New Rochelle); 2020 Nov; 9(11):591-601. PubMed ID: 33095124
[No Abstract] [Full Text] [Related]
16. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
17. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
18. Endothelial HIF2α suppresses retinal angiogenesis in neonatal mice by upregulating NOTCH signaling.
Duan LJ; Jiang Y; Fong GH
Development; 2024 Jun; 151(11):. PubMed ID: 38770916
[TBL] [Abstract][Full Text] [Related]
19. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
20. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
